What You Should Know:
– Healthcare IT company emids announced the acquisition of Canadian-based Macadamian, a global full-service healthcare software design and development consulting firm.
– The acquisition reflects emids’ response to accelerated investment in digital health and provides it with a competitive advantage as the addition of design capabilities allows it to support the entire continuum of customers’ digital transformation efforts.
– A milestone in the company’s growth plan, the acquisition also expands emids’ presence into Canada and Eastern Europe and increases its personnel to more than 2,300, with the addition of 109 expert designers, developers and engineers.
emids,a Nashville, TN-based digital engineering and transformation solutions to the healthcare and life sciences industry, today announced the acquisition of Canadian-based Macadamian, one of the largest and most respected healthcare specialist firms of its kind in the world. The acquisition marks another step in its purposeful growth strategy of adding global design-led software engineering capabilities.
Helping Clients Imagine the Future of Healthcare
Founded in 1997, Macadamian is a full-service software design and development consultancy, combining business strategy, user insights, and cutting-edge technological expertise to accelerate and bring to market breakthrough healthcare solutions. Macadamian clients include TELUS Health, Siemens Healthineers, Edwards, AMGEN, Fresenius Medical Care, and others.
emids has a strong track record of delivering complex solutions to its clients using its deep engineering and applications capabilities. The addition of Macadamian’s design-first capabilities is a perfect complement and will help both emids and Macadamian customers work with a single partner that brings in great depth and breadth in domain, design and engineering.
“Our merger with emids is a superior match of entrepreneurial mindset, complementary skill sets and healthcare specialization, and we’re excited about what we’ll be able to achieve together for our customers and for healthcare at large,” said Macadamian CEO Frederic Boulanger.
The Macadamian acquisition expands emids’ global employee footprint to more than 2,300, with 109 expert designers, developers and engineers in Canada and Eastern Europe. Macadamian’s clients run the gamut from early-stage to Fortune 500 companies with a heavy concentration in biopharmaceuticals and medical devices. Macadamian further expands emids’ IP, centers of excellence and platform capabilities, including its HealthConnect application development platform as a service, which has proven a powerful underlying architecture to accelerate the development of data-informed medical devices and digital therapeutic software applications for clients.
“Our customers have accelerated both their timelines and their investments in digital and virtual health solutions focusing on patients in the wake of COVID-19, and our acquisition of Macadamian very eloquently delivers the added sophistication that our payer, provider and life sciences partners need and demand when bringing to market digital solutions to transform the healthcare experience,” said emids Founder and CEO Saurabh Sinha. “Design has become an embedded part of the transformation value chain, and we were immediately struck by Macadamian’s design-first approach, its patented IP and innovations Lab and its sheer depth and breadth in the healthcare space.”
Financial terms of the acquisition, which closed earlier this month, were not disclosed.